13575-44-5 Usage
Uses
Used in Pharmaceutical Industry:
2-Amino-2,3-dihydro-thiazolo[4,5-b]pyridin-5(6H)-one is used as an anti-epileptic medication for the treatment of seizures associated with Lennox-Gastaut syndrome. It is effective in reducing the frequency and severity of seizures in patients with this form of epilepsy, making it a valuable therapeutic option for seizure management.
2-Amino-2,3-dihydro-thiazolo[4,5-b]pyridin-5(6H)-one is used as a sodium channel modulator for its mechanism of action in controlling seizures. It works by stabilizing the inactive state of voltage-gated sodium channels, thereby reducing the abnormal neuronal activity that leads to seizures.
The medication is typically administered orally in tablet or oral suspension form, allowing for convenient and effective treatment. However, its use may be associated with some side effects, including dizziness, headache, and nausea. Despite these potential side effects, rufinamide remains a significant therapeutic option for patients with Lennox-Gastaut syndrome, offering a means to manage their seizures and improve their quality of life.
Check Digit Verification of cas no
The CAS Registry Mumber 13575-44-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,5,7 and 5 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 13575-44:
(7*1)+(6*3)+(5*5)+(4*7)+(3*5)+(2*4)+(1*4)=105
105 % 10 = 5
So 13575-44-5 is a valid CAS Registry Number.
